Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Stalevo
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Stalevo 100mg/25mg/200mg tablets
0409010X0BBABAB
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 6,247 |
|
Stalevo 150mg/37.5mg/200mg tablets
0409010X0BBACAC
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 5,102 |
|
Stalevo 125mg/31.25mg/200mg tablets
0409010X0BBAFAF
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 4,109 |
|
Stalevo 200mg/50mg/200mg tablets
0409010X0BBADAD
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 2,739 |
|
Stalevo 175mg/43.75mg/200mg tablets
0409010X0BBAGAG
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 1,942 |
|
Stalevo 75mg/18.75mg/200mg tablets
0409010X0BBAEAE
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 1,491 |
|
Stalevo 50mg/12.5mg/200mg tablets
0409010X0BBAAAA
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 761 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.